Accelerating the Adoption of eSource in Clinical Research: A Transcelerate Point of View
Open Access
- 1 September 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Therapeutic Innovation & Regulatory Science
- Vol. 54 (5), 1141-1151
- https://doi.org/10.1007/s43441-020-00138-y
Abstract
For almost a decade, regulators and pharmaceutical industry groups have been interested in electronic source (eSource) in clinical trials (Nordo et al. in Learn Health Syst 3:e10076, 2019). eSource may provide efficiencies and value; however, eSource adoption is fragmented and slow. Acceleration of eSource adoption is a critical step in modernizing the conduct of clinical trials. The desired future state is one in which all source data, acquired through any context (e.g., healthcare delivery, chronic disease management) and actor (e.g., healthcare professional, patient, caregiver), are completely electronic, adequate in quality, and fully acceptable in clinical trial submissions by regulators worldwide. Achieving this desired future state requires transformative change management to foster adoption and minimize the burden of implementing eSource. Realizing this vision requires collaborative and dedicated efforts from multiple stakeholders, including patients, clinical trial participants, sites, technology vendors, standards organizations, regulators, payers, and sponsors. Stakeholders should align upon guidance to promote data integrity, data privacy, data security, and interoperability. The eSource revolution requires open dialogue, inclusive of shared learnings among stakeholders, to collectively and rapidly advance adoption. Adoption of eSource will optimize clinical research by enabling faster access to research data and more rapid decision-making, increasing clinical trial efficiency. Furthermore, adoption of eSource will improve data integrity by allowing direct data flow from the source to the sponsor's system, with minimal or no human intervention. This paper provides the TransCelerate point of view (POV) and recommendations to achieve the future state vision of complete utilization of eSource data in clinical trials and builds on previous TransCelerate eSource publications.This publication has 8 references indexed in Scilit:
- Use of EHRs data for clinical research: Historical progress and current applicationsLearning Health Systems, 2019
- Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010–2016: A Systematic Literature ReviewDigital Biomarkers, 2018
- Optimizing the Use of Electronic Data Sources in Clinical Trials: The Technology LandscapeTherapeutic Innovation & Regulatory Science, 2017
- A comparative effectiveness study of eSource used for data capture for a clinical research registryInternational Journal of Medical Informatics, 2017
- Optimizing the Use of Electronic Data Sources in Clinical Trials: The Landscape, Part 1Therapeutic Innovation & Regulatory Science, 2016
- An adverse event capture and management system for cancer studiesBMC Bioinformatics, 2015
- Using electronic health records for clinical research: The case of the EHR4CR projectJournal of Biomedical Informatics, 2015
- PRO Data Collection in Clinical Trials Using Mixed Modes: Report of the ISPOR PRO Mixed Modes Good Research Practices Task ForceValue in Health, 2014